Novavax’s protein-based vaccine approval fails to boost stock as demand in U.S. for shots and boosters remains low
U.S. health regulators authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option…
Read MoreU.S. health regulators authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option…
Read MoreU.S. health regulators authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option…
Read MoreU.S. health regulators have authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new…
Read MoreOTTAWA — Canada’s telecommunications regulator on Tuesday ordered Rogers Communications Inc. RCI, +2.48% RCI.B, +2.62%…
Read MoreNetflix Inc. is seeking to amend its programming deals with major entertainment studios to allow…
Read MoreBest Buy BBY, +1.44% is set to get a major restock of the highly sought-after…
Read MoreEuropean natural-gas prices nudged lower on Monday, but traders remained wary that Russia planned to…
Read MoreWhy publish a list of our picks for the best new cars that are the…
Read MoreFor the last several years, the number of homes available for sale in Charlotte, N.C.,…
Read MoreIndia’s central bank has relaxed debt-market rules for foreign portfolio investors and allowed commercial banks…
Read More